ZINC000002107582
ZINC000002107582 is a UVRAG binder. ZINC000002107582 induces Apoptosis, increases intracellular ROS levels, arrests the cell cycle at the S phase, and elevates the proportion of cells in the Sub G0 phase. ZINC000002107582 exhibits anticancer activity against breast cancer.
연구목적의 판매만을 진행합니다. 환자를 대상으로 한 판매는 하지 않습니다.
- CAS No.: 859138-65-1
- 화학식: C31H31NO6
- 분자량:513.58
-
보관:
Please store the product under the recommended conditions in the Certificate of Analysis.
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
Biological Activity
-
Chemical Information
- Protocol
- 순도&문서
- References
-
Help & FAQs
Biological Activity
제품 설명
In Vitro
ZINC000002107582 (0.195-50 μM; 24 h) potently inhibits MCF-7 cell viability with an IC50 of 5 μM, showing a concentration-dependent cytotoxic effect over 24 h[1].
ZINC000002107582 (5-10 μM; 24 h) induces dose-dependent apoptosis in MCF-7 cells, with 53.91% early apoptotic cells at IC50 (5 μM) and 80.67% total apoptotic cells at 2×IC50 (10 μM) after 24 h[1].
ZINC000002107582 (5-10 μM; 24 h) induces dose-dependent intracellular ROS accumulation in MCF-7 cells, with 71.51% ROS-positive cells at IC50 (5 μM) and 83.97% ROS-positive cells at 2×IC50 (10 μM) after 24 h[1].
ZINC000002107582 (5-10 μM; 24 h) induces S-phase cell cycle arrest and increases the Sub-G0 apoptotic population in MCF-7 cells, with more pronounced effects at 2×IC50 (10 μM) than at IC50 (5 μM) after 24 h[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Cell Line:human breast carcinoma MCF-7 cells
-
Concentration:0.195-50 μM
-
Incubation Time:24 h
-
Result:Caused a concentration-dependent reduction in cell viability.
Showed a slight reduction at 0.195-0.39 μM, a noticeable decrease at 0.781-3.125 μM, a pronounced reduction at 6.25-12.5 μM, and a significant decrease at 25-50 μM.
Reached a half-maximal inhibitory concentration (IC50) of 5 μM.
-
Cell Line:human breast carcinoma MCF-7 cells
-
Concentration:5 μM (IC50); 10 μM (2×IC50)
-
Incubation Time:24 h
-
Result:Resulted in 53.91% early apoptotic cells at IC50, while treatment at 2×IC50 resulted in 80.67% total apoptotic cells.
Showed a dose-dependent increase in apoptotic cell populations relative to untreated controls.
-
Cell Line:human breast carcinoma MCF-7 cells
-
Concentration:5 μM (IC50); 10 μM (2×IC50)
-
Incubation Time:24 h
-
Result:Reduced the G0/G1 population to 38.13%, increased the S-phase fraction to 25%, increased the Sub-G0 population to 6.82%, and decreased the G2/M phase to 25.69% at IC50.
Increased the S-phase fraction to 34%, increased the Sub-G0 population to 12.09%, decreased the G2/M phase to ~10%, and kept the G0/G1 fraction reduced relative to untreated controls at 2×IC50.
- EdU Incorporation Assay (Click Chemistry-Based DNA Synthesis Measurement)
- Detection of Apoptosis
- TUNEL staining for apoptotic DNA fragmentation
- Flow cytometric DNA-content cell-cycle staining
- Annexin V plus membrane-impermeant dye apoptosis staining
- ROS/oxidative-stress fluorescent staining
- BrdU Incorporation Assay
- Apoptosis Solutions
- Protocol for Cell Cycle
- Breast Cancer Modeling
Chemical Information
-
CAS No. 859138-65-1
-
분자량 513.58
-
화학식 C31H31NO6
-
SMILES
O=C(C1(C2=CC=CC=C2)CCN(C(CC3=C(C)C4=CC5=C(OC6=C5CCCC6)C(C)=C4OC3=O)=O)CC1)O
-
선적
Room temperature in continental US; may vary elsewhere.
-
보관
Please store the product under the recommended conditions in the Certificate of Analysis.
순도&문서
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
ZINC000002107582 Related Classifications
HY-183987 Related Classifications
Powered by Bioz